Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Meropenem And Vaborbactam

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Meropenem & vaborbactam, Meropenem + vaborbactam, 2031124-72-6, Vabomere, Meropenem / vaborbactam, Meropenem and vaborbactam
    Molecular Formula
    C29H41BN4O10S2
    Molecular Weight
    680.6  g/mol
    InChI Key
    SDJYWZHQLNEXKV-SSHSFQATSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;2-[(3R,6S)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic acid
    2.1.2 InChI
    InChI=1S/C17H25N3O5S.C12H16BNO5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4;15-11(7-9-2-1-5-20-9)14-10-4-3-8(6-12(16)17)19-13(10)18/h7-12,18,21H,5-6H2,1-4H3,(H,24,25);1-2,5,8,10,18H,3-4,6-7H2,(H,14,15)(H,16,17)/t7-,8-,9+,10+,11-,12-;8-,10-/m10/s1
    2.1.3 InChI Key
    SDJYWZHQLNEXKV-SSHSFQATSA-N
    2.1.4 Canonical SMILES
    B1(C(CCC(O1)CC(=O)O)NC(=O)CC2=CC=CS2)O.CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O
    2.1.5 Isomeric SMILES
    B1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)CC2=CC=CS2)O.C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Meropenem - Vaborbactam

    2. Meropenem And Vaborbactam

    3. Meropenem Vaborbactam Drug Combination

    4. Vabomere

    2.2.2 Depositor-Supplied Synonyms

    1. Meropenem & Vaborbactam

    2. Meropenem + Vaborbactam

    3. 2031124-72-6

    4. Vabomere

    5. Meropenem / Vaborbactam

    6. Meropenem And Vaborbactam

    7. Meropenem Mixture With Vaborbactam

    8. (4r,5s,6s)-3-[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid;2-[(3r,6s)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic Acid

    2.3 Create Date
    2014-12-31
    3 Chemical and Physical Properties
    Molecular Weight 680.6 g/mol
    Molecular Formula C29H41BN4O10S2
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count13
    Rotatable Bond Count10
    Exact Mass680.2357160 g/mol
    Monoisotopic Mass680.2357160 g/mol
    Topological Polar Surface Area260 Ų
    Heavy Atom Count46
    Formal Charge0
    Complexity1050
    Isotope Atom Count0
    Defined Atom Stereocenter Count8
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 1  
    Drug NameVABOMERE
    Active IngredientMEROPENEM; VABORBACTAM
    CompanyREMPEX PHARMS (Application Number: N209776. Patents: 8680136, 9694025)

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    J - Antiinfectives for systemic use

    J01 - Antibacterials for systemic use

    J01D - Other beta-lactam antibacterials

    J01DH - Carbapenems

    J01DH52 - Meropenem and vaborbactam